Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAZAt4kxVlbMHpagMX_Qsu-XR8Gsq_RTvkmcpfF4ECURo#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "sulfasalazine delayed release tablets are indicated a b c d 1 sulfasalazine delayed release tablets are particularly indicated in patients with ulcerative colitis who cannot take uncoated sulfasalazine tablets because of gastrointestinal intolerance and in whom there is evidence that this intolerance is not primarily the result of high blood levels of sulfapyridine and its metabolites e g patients experiencing nausea and vomiting with the first few doses of the drug or patients in whom a reduction in dosage does not alleviate the adverse gastrointestinal effects in patients with rheumatoid arthritis or juvenile rheumatoid arthritis rest and physiotherapy as indicated should be continued unlike anti inflammatory drugs sulfasalazine delayed release tablets do not produce an immediate response concurrent treatment with analgesics and or nonsteroidal anti inflammatory drugs is recommended at least until the effect of sulfasalazine delayed release tablets is apparent" assertion.
- association subject drugbank:DB00795 assertion.
- association predicate treats assertion.
- association object DOID_7148 assertion.
- association relation TreatmentIndication assertion.
- DOID_7148 category Disease assertion.
- drugbank:DB00795 category Drug assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.